SHILPAMED.NSSHILPAMED.NSNSE
Loading
Operating Income ContractionContracting
Percentile Rank93
3Y CAGR+17.5%
5Y CAGR+3.4%
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

3Y CAGR
+17.5%/yr
vs +2.3%/yr prior
5Y CAGR
+3.4%/yr
Recent acceleration
Acceleration
+15.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$2.04B-45.8%
2024$3.76B+3996.3%
2023$-96.54M-107.7%
2022$1.26B+5.5%
2021$1.19B-30.9%
2020$1.73B+48.0%
2019$1.17B+1.4%
2018$1.15B-15.0%
2017$1.35B-2.4%
2016$1.39B-